Main Article Content
Mattke, S., Seid, M. & Ma, S. (2007). Evidence for the effect of disease management: Is $1 billion a year a good investment? American Journal of Managed Care 13 (12), 670-676.
Brown, R., Peikes, D., Chen, A. & Schore, J. (2008). 15-site randomized trial of coordinated care in medicare FFS. Health Care Financing Review 30 (1), 5–25.
Esposito, D., Brown, R., Chen, A., Schore, J. & Shapiro, R. (2008). Impacts of a disease management program for dually eligible beneficiaries. Health Care Financing Review 30 (1), 27–45.
McCall, N., Cromwell, J. & Bernard, S. Evaluation of Phase I of Medicare Health Support (formerly voluntary chronic care improvement) Pilot Program under Traditional Fee-For-Service Medicare. RTI International, June 2007. Available at: http://www.cms.hhs.gov/Reports/Downloads/McCall.pdf Accessed Sep 4, 2011.
Linden, A. & Adler-Milstein, J. (2008). Medicare disease management in a policy context. Health Care Finance Review 29 (3),1-11.
American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College of Physicians (ACP) & American Osteopathic Association (AOA). Joint Principles of the Patient-Centered Medical Home. February 2007. http://www.acponline.org/running_practice/pcmh/demonstrations/jointprinc_05_17.pdf. Accessed Sep 7, 2011.
American College of Physicians. Patient Centered Medical Home. http://www.acponline.org/running_practice/pcmh Accessed Sep 7, 2011.
Centers for Medicare and Medicaid Services. Details for Multi-payer Advanced Primary Care Initiative. http://www.cms.gov/demoprojectsevalrpts/md/itemdetail.asp?itemid=cms1230016 Accessed Sep 7, 2011.
Linden, A. (2006). What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme. American Journal of Managed Care 12 (4),61-67.
Jencks, S.F., Williams, M.V. & Coleman, E.A. (2009). Rehospitalizations among Patients in the Medicare Fee-for-Service Program. New England Journal of Medicine 360, 1418-1428.
Campbell, D.T. & Stanley, J.C. (1966). Experimental and quasi-experimental designs for research. Chicago: Rand McNally.
Cook, T.D. & Campbell, D.T. (1979). Quasi-experimentation: design and analysis issues for field settings. Chicago: Rand McNally College Publishing.
Shadish, S.R., Cook, T.D. & Campbell, D.T. (2002). Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton Mifflin.
Simonton, D.K. (1977). Cross sectional time-series experiments: some suggested statistical analyses. Psychological Bulletin 84 (3), 489-502.
Matowe, L.K., Leister, C.A., Crivera, C. & Korth-Bradley, J.M. (2003). Interrupted times series analysis in clinical research. Annals of Pharmacotherapy 37, 1110-1116.
Linden, A. & Adams, J.L. (2010). Applying a propensity-score based weighting model to interrupted time series data: improving causal inference in program evaluation. Journal of Evaluation in Clinical Practice. Online version published October 25, 2010.
Newey, W.K. & West, K.D. (1987). A simple, positive semi-definite, heteroskedasticity and autocorrelation consistent covariance matrix. Econometrica 55, 703–708.
Liang, K-Y. & Zeger, S.L. (1986). Longitudinal data analysis using generalized linear models. Biometrika 73, 13–22.
U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda: MD, 2010.
Ljung, G.M. & Box, G.E.P. (1978). On a measure of lack of fit in time series models. Biometrika 65, 297–303.
Naylor, M.D., Brooten, D., Campbell, R., Jacobsen, B.S., Mezey, M.D., Pauley, M.V. & Schwartz, J.S. (1999). Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. Journal American Medical Association 281, 613-620.
Naylor, M.D., Brooten, D.A., Campell, R.L., Maislin, G., McCauley, K.M. & Schwartz, J.S. (2004). Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. Journal American Geriatric Society 52, 675-684.
Coleman, E.A. & Chalmers, S. (2006). The care transitions intervention: results of a randomized controlled trial. Archives of Internal Medicine 166, 1822-1828.
Agency for Healthcare Research and Quality. Comparative Effectiveness of Case Management for Adults with Medical Illness and Complex Care Needs. Available at: http://www.effectivehealthcare.ahrq.gov/ehc/products/240/732/Case-Management_Draft-Report_CER_20110726.pdf Accessed Sep 19, 2011.
Koechler, J.A., Abramowitz, P.W., Swim, S.E. & Daniels, C.E. (1989). Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. American Journal of Hospital Pharmacy 46, 729-732.
Hepler, C.D. & Strand, L.M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy 47, 533-543.
Strand, L.M., Morley, P.C. & Cipolle, R.J. (1990). Drug-related problems: their structure and function. Annals of Pharmacotherapy 24, 1093-1097.
Linden, A., Adams, J. & Roberts, N. (2003). An assessment of the total population approach for evaluating disease management program effectiveness. Disease Management 6 (2), 93-102.
Linden, A. (2007). Estimating the effect of regression to the mean in health management programs. Disease Management and Health Outcomes 15 (1), 7-12.
Ezekiel, E.J. (1996). Cost savings at the end of life: What do the data show? Journal American Medical Association 275, 1907-1914.
Hogan, C., Lunney, J., Gabel, J. & Lynn, J. (2001). Medicare beneficiaries’ costs of care in the last year of life. Health Affairs 204, 188–195.
Barnato, A., McClellan, M.B., Kagay, C.R. & Garber, A.M. (2004). Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Services Research 39 (2), 363–376.
Campbell, D., Lynn, J., Louis, T. & Shugarman, L. (2004). Medicare program expenditures associated with hospice use. Annals of Internal Medicine 140, 269–277.